Cerus
CERS
#7439
Rank
NZ$0.73 B
Marketcap
NZ$3.82
Share price
-2.14%
Change (1 day)
19.43%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -NZ$12.43 Million

According to Cerus's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2024 the company made an earning of -NZ$19.82 Million, an increase over its 2023 earnings that were of -NZ$48.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$12.43 Million-37.31%
2024 -NZ$19.82 Million-58.95%
2023 -NZ$48.28 Million-20.74%
2022 -NZ$60.91 Million-25.7%
2021 -NZ$81.98 Million-11.99%
2020 -NZ$93.14 Million-14%
2019 -NZ$0.11 Billion21.73%
2018 -NZ$88.97 Million-0.65%
2017 -NZ$89.55 Million-10.96%
2016 -NZ$0.11 Billion4.24%
2015 -NZ$96.49 Million50.99%
2014 -NZ$63.91 Million-10.08%
2013 -NZ$71.07 Million184.13%
2012 -NZ$25.02 Million-7.91%
2011 -NZ$27.16 Million
2009 -NZ$38.36 Million-24.69%
2008 -NZ$50.94 Million-25.2%
2007 -NZ$68.1 Million330.54%
2006 -NZ$15.82 Million1.49%
2005 -NZ$15.59 Million-61.02%
2004 -NZ$39.99 Million
2002 -NZ$98.9 Million10.02%
2001 -NZ$89.89 Million34.25%
2000 -NZ$66.96 Million61.02%
1999 -NZ$41.59 Million-18.81%
1998 -NZ$51.22 Million93.08%
1997 -NZ$26.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$5.45 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
NZ$24.38 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.40 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$15.84 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA